Loading...
Images of Keri Aitchison
(0 from 0 )News
Less is more: how risk-based monitoring is changing trials - PMLiVE
www.pmlive.com
Amgen started to implement RBM in 2012, according to Keri Aitchison, director of the company's global development operations. However, rather than rely on systems developed by CRO partners Amgen opted for an internally-developed platform that relies on modelling trial design, feasibility and cost ...
sorted by relevance / date